You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 103 No. 1, January 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ceftriaxone

A New Cephalosporin With Aqueous Humor Levels Effective Against Enterobacteriaceae

Judith L. Axelrod, MD; James C. Newton, MD; Chalermpong Sarakhun, MD; Richard D. Lester, MD; Kenneth Merhige, MD; Rochelle L. Peck, MD; Thomas J. Francomano, MD; Mohammed Z. Sheikh

Arch Ophthalmol. 1985;103(1):71-72.


Abstract

• One- or two-gram doses of ceftriaxone were administered intravenously to 30 patients before cataract extraction. With the 1-g dose, mean aqueous humor concentrations of 0.93 and 0.88 µg/mL were found at approximately 2 and 12 hours after administration, respectively. With the 2-g dose, a mean level of 2.47 µg/mL was observed at two hours; levels of more than 2 µg/mL were found in two patients 13 hours after administration. Both the 1- and 2-g doses thus produce aqueous humor levels many times higher than the minimum inhibitory concentration of ceftriaxone for 90% of most Enterobacteriaceae, excluding Pseudomonas. Concentrations adequate for Staphylococcus aureus and Staphylococcus epidermidis were not, however, obtained.



Author Affiliations

From the Departments of Medicine (Dr Axelrod and Mr Sheikh) and Ophthalmology (Drs Newton, Sarakhun, Lester, Merhige, Peck, and Francomano), St Luke's-Roosevelt Hospital Center, New York City.


Footnotes

Accepted for publication Aug 23, 1984.

Reprint requests to Division of Infectious Diseases and Epidemiology, Department of Medicine, St Luke's-Roosevelt Hospital Center, 421 W 113th St, New York, NY 10025 (Dr Axelrod).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ocular Manifestations of Whipple Disease: An Atypical Presentation
Williams et al.
Arch Ophthalmol 1998;116:1232-1234.
ABSTRACT | FULL TEXT  

Results of the Endophthalmitis Vitrectomy Study: A Randomized Trial of Immediate Vitrectomy and of Intravenous Antibiotics for the Treatment of Postoperative Bacterial Endophthalmitis
Endophthalmitis Vitrectomy Study Group
Arch Ophthalmol 1995;113:1479-1496.
ABSTRACT  

The Endophthalmitis Vitrectomy Study
Doft
Arch Ophthalmol 1991;109:487-489.
ABSTRACT  

Subconjunctival Administration of Ceftazidime in Pigmented Rabbit Eyes
Shockley et al.
Arch Ophthalmol 1986;104:266-268.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.